Israel Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

1.1 List of Figures
1.2 List of Tables

2.1 Executive Summary
2.2 Key Highlights: Facts About the Israeli Healthcare Market
2.3 Key Highlights: Healthcare Startups in Israel
2.4 Key Events: Israeli Healthcare Timeline, 2016-22
2.5 Key Events: Israeli Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-22
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Israel, 2021

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Israel
3.5 Pharmaceutical Market - Medical Tourism, Israel
3.6 Pharmaceutical Market - Market Segments
3.7 Pharmaceutical Market - Market Segments, Generics, Israel
3.8 Pharmaceutical Market - Market Segments, Biologics and Biosimilars, Israel
3.9 Pharmaceutical Market - Market Segment, Over-the-Counter Medicines, Israel
3.10 COVID-19 Epidemiology, Israel
3.11 COVID-19 Impact and Developments in the Healthcare Market, Israel
3.12 COVID-19 Clinical Trials Landscape, Israel
3.13 Pharmaceutical Market - Major Players

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Segments
4.3 Medical Devices Market - Cardiovascular Devices Market
4.4 Medical Devices Market - Hospital Supplies Market
4.5 Medical Devices Market - Orthopedic Devices Market
4.6 Medical Devices Market - Neurology Devices Market
4.7 Medical Devices Market - General Surgery Devices Market
4.8 Medical Devices Market - Diagnostic Market
4.9 Medical Devices Market - Major Players

5.1 Drivers
5.2 Barriers

6.1 Deal Analysis: Pharmaceutical Market, Israel, 2021-22
6.2 Deal Analysis: Medical Device Market, Israel, 2021-22

7.1 Healthtech Landscape, Israel
7.2 Healthtech Deals Landscape, Israel
7.3 Key Healthtech Deals, Israel
7.4 Adoption of Technology in Healthcare, Israel
7.5 Digital Statistics, Israel
7.6 Digital Regulations, Israel
7.7 Healthtech Landscape: Benefits and Risks, Israel

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

Table 1: COVID-19 indicators (number of cases), Global and Israel, 2022
Table 2: COVID-19-related travel restrictions, Israel, 2020-22
Table 3: Available COVID-19 IVD products, Israel, 2021-22
Table 4: Pipeline COVID-19 IVD products, Israel, 2021-22
Table 5: Approved vaccines, Israel, 2022
Table 6: COVID-19 vaccine trials, Israel, 2022
Table 7: Medical devices market, major segments ($M), Israel, 2021
Table 8: Cardiovascular devices market, revenue ($M) and market share (%) of major companies, Israel, 2021
Table 9: Hospital supplies market, revenue ($M) and market share (%) of major companies, Israel, 2021
Table 10: Orthopedic devices market, revenue ($M) and market share (%) of major companies, Israel, 2021
Table 11: Neurology devices market, revenue ($M) and market share (%) of major companies, Israel, 2021
Table 12: General surgery devices market, revenue ($M) and market share (%) of major companies, Israel, 2021
Table 13: Health insurance contributions, Israel, 2022
Table 14: Comparison between health plans, group commercial, and individual commercial, Israel, 2022
Table 15: Pharmacist margin, Israel, 2022
Table 16: Patent approval fees, Israel, 2022
Table 17: Trademark fees, Israel, 2022
Table 18: CCS, Israel, 2022
Table 19: Trade fairs, Israel, 2022

Figure 1: Pharmaceutical market, revenue ($B), Israel, 2014-21
Figure 2: Medical devices market, revenue ($B), Israel, 2014-21
Figure 3: Healthcare start-ups in Israel, 2022
Figure 4: Country profile, Israel, 2021
Figure 5: Pharmaceutical market, revenue ($B), Israel, 2014-21
Figure 6: Pharmaceutical market, revenue forecast ($B), Israel, 2022-27
Figure 7: Pharmaceutical exports ($B), Israel, 2014-21
Figure 8: Top export partners, Israel, 2021
Figure 9: Pharmaceutical imports ($B), Israel, 2014-21
Figure 10: Top import partners, Israel, 2021
Figure 11: Pharmaceutical supply channel, Israel, 2022
Figure 12: Medical tourism providers, Israel, 2022
Figure 13: Top medical treatments offered under medical tourism, Israel, 2022
Figure 14: Reasons to travel to Israel for medical treatment, Israel, 2022
Figure 15: Israel’s strengths in the field of personalized medicine, 2022
Figure 16: OTC medicines market ($M), major distribution channels, Israel, 2021
Figure 17: OTC market revenue ($M), Israel, 2013-21
Figure 18: OTC medicines market ($M), major categories, Israel, 2021
Figure 19: COVID-19 cases, Israel, 2020-22
Figure 20: COVID-19 deaths, Israel, 2020-22
Figure 21: COVID-19 stringency index (based on the share of people that are vaccinated), Israel, 2020-22
Figure 22: COVID-19 containment and health index, Israel, 2020-22
Figure 23: Objectives of Magen Israel, 2022
Figure 24: Probability of COVID-19 epidemic spread (R-Index), Israel, 2020-22
Figure 25: Visualization of the risk of epidemic spread based on R-Index, COVID-19, Israel, 2022
Figure 26: Traffic light plan, Israel, 2022
Figure 27: COVID-19 fiscal stimulus timeline, Israel, 2020-21
Figure 28: Collaborations of Israel Institute of Biological Research during COVID-19, Israel, 2020-22
Figure 29: High risk groups for COVID-19 , Israel, 2022
Figure 30: COVID-19 vaccine doses administration - number of vaccine doses administered, Israel, 2022
Figure 31: COVID-19 vaccine doses administered as per dose (in %), Israel, 2020-22
Figure 32: COVID-19 vaccine doses administered as per age group, Israel, 2022
Figure 33: Some of the factors for Israel’s vaccination success, Israel, 2022
Figure 34: COVID-19 clinical trials count by trial status, Israel, 2021-22
Figure 35: COVID-19 clinical trials count by trial phase, Israel, 2021-22
Figure 36: Top COVID-19 clinical trials sponsors by trial count, Israel, 2021-22
Figure 37: Medical devices market, revenue ($B), Israel, 2015-21
Figure 38: Medical devices market, revenue forecast ($B), Israel, 2022-28
Figure 39: Cardiovascular devices market, revenue ($M), Israel, 2017-27
Figure 40: Cardiovascular devices market, revenue ($M), Israel, 2017-27
Figure 41: Cardiovascular devices market, market share of major players (%), Israel, 2021
Figure 42: Hospital supplies market, revenue ($M), Israel, 2017-27
Figure 43: Hospital supplies market, market share of major players (%), Israel, 2021
Figure 44: Orthopedic devices market, revenue ($M), Israel, 2017-27
Figure 45: Orthopedic devices market, market share of major players (%), Israel, 2021
Figure 46: Neurology devices market, revenue ($M), Israel, 2017-27
Figure 47: Neurology devices market, market share of major players (%), Israel, 2021
Figure 48: General surgery devices market, revenue ($M), Israel, 2017-27
Figure 49: General surgery devices market, market share of major players (%), Israel, 2021
Figure 50: Diagnostic market, revenue ($M), Israel, 2017-2021
Figure 51: Diagnostic market, revenue ($M), Israel, 2022-27
Figure 52: Medical devices market, revenue ($B) of major companies, Israel, 2020
Figure 53: Deal value and deal count, pharmaceutical market, Israel, 2021-22
Figure 54: Deal value and deal count subtypes, pharmaceutical market, Israel, 2021-22
Figure 55: Deal value and deal count, quarterly, pharmaceutical market, Israel, 2021-22
Figure 56: Top therapy areas by deal value ($M), pharmaceutical market, Israel, 2021-22
Figure 57: Top therapy areas by deal count, pharmaceutical market, Israel, 2021-22
Figure 58: VC deals by quarter, pharmaceutical market, Israel, 2021-22 (by value and by number)
Figure 59: PE deals by quarter, pharmaceutical market, Israel, 2021-22 (by value and by number)
Figure 60: Deal value and deal count, medical devices market, Israel, 2021-22
Figure 61: Deal value and deal count subtypes, medical devices market, Israel, 2021-22
Figure 62: Deal value and deal count, quarterly, medical devices market, Israel, 2021-22
Figure 63: Top equipment sectors by deal value ($M), medical devices market, Israel, 2021-22
Figure 64: Top equipment sectors by deal count, medical devices market, Israel, 2021-22
Figure 65: M&A deals by quarter, medical devices market, Israel, 2021-22 (by value and by number)
Figure 66: VC deals by quarter, medical devices market, Israel, 2021-22 (by value and by number)
Figure 67: Fundings in subsectors of digital health, Israel, 2021
Figure 68: Deal value ($M) and deal count, Healthtech, Israel, 2021-22
Figure 69: Deal value ($M) and deal count by sector, Healthtech, Israel, 2021-22
Figure 70: Major VC deals by value and round type, Digital Health, Israel, Q2 2021
Figure 71: International collaborations of Ministry of Information and Technology, Healthtech, Israel, 2022
Figure 72: Most promising digital health firms, Israel, 2021
Figure 73: Technology in COVID-19, Israel, 2022
Figure 74: National digital program, Israel, 2021-22
Figure 75: National plan for digital health as a national growth engine, Israel, 2022
Figure 76: Overview of healthcare system, Israel, 2022
Figure 77: Groups exempted from insurance contribution, Israel, 2022
Figure 78: HMOs, Israel, 2022
Figure 79: Rights of the people insured under National Health insurance law, Israel, 2022
Figure 80: Services offered under complementary insurance plan, Israel, 2022
Figure 81: Private insurance coverage (% of the total population), Israel, 2013-18